Last October, the Drug Enforcement Agency (DEA) and the Department of Health and Human Services (HHS) extended the COVID-era telehealth controlled substance prescribing flexibilities through December 31, 2024. They planned to introduce new standards by this fall. But the agencies need more time to consider all the feedback they have received and, on November 19, […]
Tag Archives: DEA
You could almost hear the collective sigh of relief from healthcare providers around the country on May 9, 2023. Two days before the end of the public health emergency (PHE), the Drug Enforcement Agency issued a Temporary Rule that extends current flexibilities for telehealth prescribing of controlled substances for another six months. The Temporary Rule […]
During the COVID-19 pandemic, the government extended much-needed flexibilities surrounding telehealth to facilitate access to care. Many of these flexibilities were lifesaving. This included allowing the prescription of controlled substances via telehealth to treat substance use disorders and psychiatric conditions. Background Prior to the pandemic, in most instances, a patient required at least one in-person […]